Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/22/24 16:12 | 11/20/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | 3 | S | -304 | 27.97 | 0 | -11 | 327 | D | |||||||||||||||
11/22/24 16:11 | 11/20/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | 2 | S | -177 | 27.08 | 0 | -7 | 365 | D | |||||||||||||||
11/22/24 16:09 | 11/20/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Barnett Eva Renee | NY | O | CFO | 3 | S | -353 | 28.00 | 0 | -13 | 339 | D | |||||||||||||||
11/22/24 16:08 | 11/20/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Salzmann Peter | NY | DO | CEO | 3 | S | -818 | 27.06 | 0 | -30 | 1,004 | D | |||||||||||||||
10/25/24 16:23 | 10/23/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Geffner Michael | NY | O | Chief Me | 1 | S | -94 | 29.53 | 0 | -3 | 135 | D | |||||||||||||||
10/25/24 16:21 | 10/23/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NY | O | CTO | 1 | S | -81 | 29.53 | 0 | -3 | 142 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |